Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas
暂无分享,去创建一个
Satoshi Matsumoto | Charis Eng | P. Watson | C. Eng | K. Kurose | Xiao-ping Zhou | S. Matsumoto | Xiao-Ping Zhou | Peter H. Watson | Keisuke Kurose | Kristie Gilley | K. Gilley
[1] J. Lawrence,et al. The WFDC1 gene encoding ps20 localizes to 16q24, a region of LOH in multiple cancers , 2000, Mammalian Genome.
[2] C. Scriver,et al. The Metabolic and Molecular Bases of Inherited Disease, 8th Edition 2001 , 2001, Journal of Inherited Metabolic Disease.
[3] A. Wellmann,et al. Presence of genetic alterations in microdissected stroma of human colon and breast cancers. , 2001, Journal of molecular medicine.
[4] C. Eng,et al. Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers. , 2000, Journal of the National Cancer Institute.
[5] I. Tomlinson,et al. Loss of heterozygosity analysis: Practically and conceptually flawed? , 2002, Genes, chromosomes & cancer.
[6] J. Bouchard,et al. The K–Cl cotransporter KCC3 is mutant in a severe peripheral neuropathy associated with agenesis of the corpus callosum , 2002, Nature Genetics.
[7] S. Lemeshow,et al. Genetic model of multi-step breast carcinogenesis involving the epithelium and stroma: clues to tumour-microenvironment interactions. , 2001, Human molecular genetics.
[8] L. Mulligan,et al. Immunohistochemical evidence of loss of PTEN expression in primary ductal adenocarcinomas of the breast. , 1999, The American journal of pathology.
[9] T. Mak,et al. Regulation of PTEN transcription by p53. , 2001, Molecular cell.